[1]
Rodrigues, F.F.O. et al. 2018. PROGNOSTIC EVALUATION OF PATIENTS WITH TRIPLE NEGATIVE IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY. Mastology. 28, (Jun. 2018), 48.